For the year ending 2025-12-31, CALX had $99,924K increase in cash & cash equivalents over the period. $115,518K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Revenue | 1,000,010 |
| Adjusted cost of revenue | 427,718 |
| Adjusted sales and marketing operating expenses | 217,904 |
| Adjusted research and development operating expenses | 167,020 |
| Adjusted general and administrative operating expenses | 77,483 |
| Other segment items | 88,895 |
| Interest income and other expenses, net | 13,178 |
| Income taxes | 16,284 |
| Net income (loss) | 17,884 |
| Stock-based compensation | 87,929 |
| Depreciation and amortization | 17,710 |
| Deferred income taxes | 12,911 |
| Net accretion of available-for-sale securities | 3,697 |
| Accounts receivable, net | 20,046 |
| Inventory | 31,010 |
| Prepaid expenses and other assets | -17,297 |
| Accounts payable | 21,509 |
| Accrued liabilities | 3,017 |
| Deferred revenue | 2,643 |
| Other long-term liabilities | 8,806 |
| Net cash provided by operating activities | 134,953 |
| Purchases of property and equipment | 19,435 |
| Purchases of marketable securities | 220,839 |
| Sales of marketable securities | 28,142 |
| Maturities of marketable securities | 205,759 |
| Net cash used in investing activities | -6,373 |
| Proceeds from common stock issuances related to employee benefit plans | 65,196 |
| Repurchases of common stock | 93,630 |
| Payments related to financing arrangements | 0 |
| Net cash provided by (used in) financing activities | -28,434 |
| Effect of exchange rate changes on cash and cash equivalents | -222 |
| Net increase (decrease) in cash and cash equivalents | 99,924 |
| Cash and cash equivalents at beginning of year | 43,162 |
| Cash and cash equivalents at end of year | 143,086 |
CALIX, INC (CALX)
CALIX, INC (CALX)